会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • TESTING EFFICACY FOR CELIAC DISEASE
    • CELIAC疾病的测试效果
    • WO2011000773A1
    • 2011-01-06
    • PCT/EP2010/058997
    • 2010-06-24
    • DSM IP Assets B.V.BRUINS, Maaike, JohannaEDENS, Luppo
    • BRUINS, Maaike, JohannaEDENS, Luppo
    • G01N33/564
    • G01N33/564G01N2800/06G06Q99/00
    • We describe a method to determine effectiveness of a compound or composition in treatment of celiac disease or gluten intolerance, the method comprising: - administration of the compound or composition to one or more human patients who were on a gluten-free diet for 10 years or less, preferably 6 years or less; - challenge with gluten of the one or more human patients who were administered the compound or composition; and - determining whether there is a change in condition of celiac disease or gluten intolerance of the one or more patients that results from administration of the compound or composition and challenge with gluten; whereby no significant change in condition indicates that the compound or composition would be effective in treating celiac disease or gluten intolerance.
    • 我们描述了一种确定化合物或组合物治疗乳糜泻或麸质不耐症的有效性的方法,该方法包括:将化合物或组合物施用于一个或多个无麸质饮食的人类患者10年,或 少于6岁以下; - 对施用化合物或组合物的一个或多个人类患者的面筋进行挑战; 以及 - 确定由所述化合物或组合物的施用导致的一种或多种患者的腹腔疾病或麸质不耐受状况是否发生变化并用面筋攻击; 因此条件没有显着变化表明化合物或组合物将有效治疗乳糜泻或麸质不耐受。
    • 8. 发明申请
    • MEDICAMENT AND METHOD FOR TREATING INNATE IMMUNE RESPONSE DISEASES
    • 治疗免疫应答疾病的药物和方法
    • WO2015086737A1
    • 2015-06-18
    • PCT/EP2014/077355
    • 2014-12-11
    • DSM IP ASSETS B.V.
    • BRUINS, Maaike JohannaEDENS, LuppoNAN, Lenneke
    • A23L1/03A21D8/04A61K38/48C12N9/62C11D3/386
    • A61K38/488A21D8/042A23L5/25A23L29/06A23V2002/00A61K9/0053A61K38/482C12C5/004C12N9/62C12Y304/21026C12Y304/23018C12Y304/23019A61K2300/00
    • This invention relates to a medicament or a dietary supplement comprising the Aspergillus niger aspergilloglutamic peptidase that is capable of hydrolyzing plant food allergens, and more particularly, alpha-amylase/trypsin inhibitors, thereby treating diseases due to an innate immune response in humans, and / or allowing to delay the onset of said diseases. The present invention relates to the discovery that the Aspergillus niger aspergilloglutamic peptidase is capable of hydrolyzing alpha-amylase/trypsin inhibitors that are present in wheat and related cereals said inhibitors being strong inducers of innate immune response. Furthermore, the present invention relates to a method for hydrolyzing alpha-amylase/trypsin inhibitors comprising incubating a composition for food consumption comprising alpha-amylase/trypsin inhibitors with the Aspergillus niger aspergilloglutamic peptidase, wherein the inhibitors are hydrolyzed. It also relates to an enzyme composition comprising the Aspergillus niger aspergilloglutamic peptidase and an additional enzyme, and to foodstuff comprising the Aspergillus niger aspergilloglutamic peptidase.
    • 本发明涉及一种药物或膳食补充剂,其包含能够水解植物食物过敏原的黑曲霉曲霉菌肽酶,更具体地,涉及α-淀粉酶/胰蛋白酶抑制剂,从而治疗由于人的先天免疫应答引起的疾病,和/ 或允许延迟所述疾病的发作。 本发明涉及黑曲霉曲霉菌肽酶能够水解存在于小麦和相关谷物中的α-淀粉酶/胰蛋白酶抑制剂的发现,所述抑制剂是先天免疫应答的强诱导剂。 此外,本发明涉及水解α-淀粉酶/胰蛋白酶抑制剂的方法,包括将包含α-淀粉酶/胰蛋白酶抑制剂的食物组合物与黑曲霉曲霉菌肽酶一起孵育,其中所述抑制剂被水解。 它还涉及包含黑曲霉曲霉菌肽酶和另外的酶的酶组合物以及包含黑曲霉曲霉菌肽酶的食品。
    • 9. 发明申请
    • USE OF THE ASPERGILLUS NIGER ASPERGILLOGLUTAMIC PEPTIDASE TO IMPROVE ANIMAL PERFORMANCE
    • 使用青US ER ER ER IC IC IC IC ASE TO ANCE ANCE ANCE ANCE ANCE ANCE ANCE ANCE ANCE ANCE ANCE ANCE ANCE ANCE ANCE ANCE ANCE
    • WO2015086735A1
    • 2015-06-18
    • PCT/EP2014/077353
    • 2014-12-11
    • DSM IP ASSETS B.V.
    • BRUINS, Maaike JohannaEDENS, LuppoLENEKE, Nan
    • A23K1/165A23K1/18C12N9/62
    • A23K20/189A23K10/14A23K20/174A23K20/30A23K50/30A23K50/75A61K38/488C12Y304/23019
    • This invention relates to the use of the Aspergillus niger aspergilloglutamic peptidase in a feed composition containing cereals, pulses, oilseeds, and/or tubers to improve animal performance, reduce nitrogen excretion and/or reduce intestinal inflammation. Furthermore, the present invention relates to a feed composition or a feed additive comprising the Aspergillus niger aspergilloglutamic peptidase. The present invention relates to the discovery that the Aspergillus niger aspergilloglutamic peptidase is capable of efficiently hydrolyzing alpha- amylase/trypsin inhibitors that are present in wheat, barley and related cereal species, as well as hydrolyzing trypsin inhibitors that are present in pulses, oilseeds, and tubers. Furthermore, the present invention relates to a method of improving animal performance comprising improving feed conversion ratio, and/or improving daily weight gain, and/or reducing intestinal inflammation, and/or reducing nitrogen excretion in an animal fed a feed stuff containing alpha- amylase and/or trypsin inhibitors, comprising orally administering a sufficient amount of the Aspergillus niger aspergilloglutamic peptidase. It also relates to the pretreatment of feedstuff with the Aspergillus niger aspergilloglutamic peptidase.
    • 本发明涉及黑曲霉曲霉菌肽酶在含有谷物,豆类,油籽和/或块茎的饲料组合物中的用途,以改善动物性能,减少氮排泄和/或减少肠道炎症。 此外,本发明涉及包含黑曲霉曲霉菌肽酶的饲料组合物或饲料添加剂。 本发明涉及黑曲霉曲霉菌肽酶能够有效水解存在于小麦,大麦和相关谷类物种中的α-淀粉酶/胰蛋白酶抑制剂以及水解存在于脉冲,油籽中的胰蛋白酶抑制剂的发现, 和块茎。 此外,本发明涉及一种改善动物性能的方法,包括改善饲料转化率,和/或改善每日体重增加,和/或减少肠道炎症,和/或减少饲喂含α-淀粉样蛋白饲料的动物的氮排泄, 淀粉酶和/或胰蛋白酶抑制剂,包括口服施用足量的黑曲霉曲霉菌肽酶。 它还涉及用黑曲霉曲霉菌肽酶预处理饲料。